In patients with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control as:

• Monotherapy
• Dual Therapy: in combination with metformin HCl or with a sulphonylurea or with a PPARγ agonist (i.e.,
  thiazolidinediones) when the treatment with the single agent alone with diet and exercise does not provide
  adequate glycemic control.
• Triple Therapy: in combination with metformin HCl and a sulphonylurea or with metformin HCl and a PPARγ (i.e., thiazolidinediones) when dual therapy with these agents, with diet and exercise, does not provide adequate glycemic control.
• Combination with Insulin.